This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biancotto, A. Articles by Hirsch, I. Search for Related Content PubMed PubMed Citation Articles by Biancotto, A. Articles by Hirsch, I.

Dual Role of Prostratin in Inhibition of Infection and Reactivation of Human Immunodeficiency Virus from Latency in Primary Blood Lymphocytes and Lymphoid Tissue

Unité de Pathogénie des Infections à Lentivirus, Parc Scientifique et Technologique de Luminy, INSERM U372, Marseille, France,¹ Laboratory of Molecular and Cellular Biophysics, National Institute of Child Health and Human Development, Bethesda, Maryland,² AIDS ReSearch Alliance, West Hollywood, California³

Received 8 January 2004/ Accepted 19 May 2004

To design strategies to purge latent reservoirs of human immunodeficiency virus type 1 (HIV-1), we investigated mechanisms by which a non-tumor-promoting phorbol ester, prostratin, inhibits infection of CD4⁺ T lymphocytes and at the same time reactivates virus from latency. CD4⁺ T lymphocytes from primary blood mononuclear cells (PBMC) and in blocks of human lymphoid tissue were stimulated with prostratin and infected with HIV-1 to investigate the effects of prostratin on cellular susceptibility to the virus. The capacity of prostratin to reactivate HIV from latency was tested in CD4⁺ T cells harboring preintegrated and integrated latent provirus. Prostratin stimulated CD4⁺ T cells in an aberrant way. It induced expression of the activation markers CD25 and CD69 but inhibited cell cycling. HIV-1 uptake was reduced in prostratin-stimulated CD4⁺ T PBMC and tissues in a manner consistent with a downregulation of CD4 and CXCR4 receptors in these systems. At the postentry level, prostratin inhibited completion of reverse transcription of the viral genome in lymphoid tissue. However, prostratin facilitated integration of the reverse-transcribed HIV-1 genome in nondividing CD4⁺ T cells and facilitated expression of already integrated HIV-1, including latent forms. Thus, while stimulation with prostratin restricts susceptibility of primary resting CD4⁺ T cells to HIV infection at the virus cell-entry level and at the reverse transcription level, it efficiently reactivates HIV-1 from pre- and postintegration latency in resting CD4⁺ T cells.

This article has been cited by other articles:

• Wender, P. A., Kee, J.-M., Warrington, J. M. (2008). Practical Synthesis of Prostratin, DPP, and Their Analogs, Adjuvant Leads Against Latent HIV. Science 320: 649-652 [Abstract] [Full Text]  
• Klichko, V., Archin, N., Kaur, R., Lehrman, G., Margolis, D. (2006). Hexamethylbisacetamide Remodels the Human Immunodeficiency Virus Type 1 (HIV-1) Promoter and Induces Tat-Independent HIV-1 Expression but Blunts Cell Activation. J. Virol. 80: 4570-4579 [Abstract] [Full Text]  
• Gondois-Rey, F., Biancotto, A., Fernandez, M. A., Bettendroffer, L., Blazkova, J., Trejbalova, K., Pion, M., Hirsch, I. (2006). R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L- CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. J. Virol. 80: 854-865 [Abstract] [Full Text]  
• Swiggard, W. J., Baytop, C., Yu, J. J., Dai, J., Li, C., Schretzenmair, R., Theodosopoulos, T., O'Doherty, U. (2005). Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli. J. Virol. 79: 14179-14188 [Abstract] [Full Text]  
• Trushin, S. A., Bren, G. D., Asin, S., Pennington, K. N., Paya, C. V., Badley, A. D. (2005). Human Immunodeficiency Virus Reactivation by Phorbol Esters or T-Cell Receptor Ligation Requires both PKC{alpha} and PKC{theta}. J. Virol. 79: 9821-9830 [Abstract] [Full Text]